Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Prince Pharmaceutical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-53.54	15.31	51.55	-8.3	-33.8
Depreciation & Amortization	62.49	58.56	52.35	45.34	27.77
Other Amortization	-	-	-	0.88	0.6
Loss (Gain) From Sale of Assets	0.14	-0.06	-0.06	-0.09	0.25
Stock-Based Compensation	9.32	6.27	2.93	-	2.02
Provision & Write-off of Bad Debts	-	-0.1	0.08	0.02	-0.11
Other Operating Activities	-3.01	3.74	12.65	-0.03	-5.98
Change in Accounts Receivable	-8.44	-32.4	-3.72	-14.86	0.69
Change in Inventory	0.65	7.74	-24.42	-32.09	-14.3
Change in Accounts Payable	23.23	29.47	-13.09	29	6.11
Change in Unearned Revenue	2.83	-12.17	3.87	-	-
Change in Other Net Operating Assets	12.55	-13.87	9.51	22.49	16.54
Operating Cash Flow	46.21	62.5	91.65	42.36	-0.21
Operating Cash Flow Growth	-26.07%	-31.81%	116.38%	-	-
Capital Expenditures	-18	-62.05	-19.53	-40.98	-186.52
Sale of Property, Plant & Equipment	1.14	0.06	0.06	0.12	0.07
Sale (Purchase) of Intangibles	-	-0.19	-0.28	-0.3	-0.26
Other Investing Activities	-0.46	-5.82	-20.27	2.36	-0.19
Investing Cash Flow	-17.32	-68.01	-40.02	-38.79	-186.9
Long-Term Debt Issued	-	-	-	68.45	309.91
Short-Term Debt Repaid	-	-	-30	-45	-258.54
Long-Term Debt Repaid	-39.5	-38.7	-22.17	-11.59	-4.93
Total Debt Repaid	-39.5	-38.7	-52.17	-56.59	-263.47
Net Debt Issued (Repaid)	-39.5	-38.7	-52.17	11.86	46.43
Issuance of Common Stock	-	100.24	-	-	22.7
Common Dividends Paid	-9.15	-5.43	-	-	-
Financing Cash Flow	-48.65	56.11	-52.17	11.86	69.13
Net Cash Flow	-19.76	50.61	-0.54	15.42	-117.98
Free Cash Flow	28.21	0.45	72.13	1.38	-186.73
Free Cash Flow Growth	6197.10%	-99.38%	5118.96%	-	-
Free Cash Flow Margin	4.09%	0.06%	10.12%	0.31%	-63.13%
Free Cash Flow Per Share	0.77	0.01	2.16	0.04	-5.71
Cash Interest Paid	10.27	10.46	8.92	5.59	3.66
Cash Income Tax Paid	4.46	0.11	0.02	-0.01	-0.01
Levered Free Cash Flow	42.18	-3.52	46.01	4.07	-184.78
Unlevered Free Cash Flow	48.59	3.02	51.6	8.79	-181.47
Change in Net Working Capital	-25.62	15.68	26.23	-4.54	-6.34

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.